EP1529038 - Bibliographic data

BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY

Last update	13/07/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	NOVARTIS AG Lichtstrasse 35 4056 s BASEL Suisse NOVARTIS PHARMA GMBH Brunner Strasse 59 s 1230 Wien Autriche
(72) Inventors	CUENOUD, Bernard Rue Volaire 7 CH-1005 Lausanne Suisse FAIRHURST, Robin, Alec Novartis Horsham Research Centre Wimblehurst Road Horsham West Sussex RH12 5AB Royaume-Uni TAYLOR, Roger, John Novartis Horsham Research Centre Wimblehurst Road Horsham West Sussex RH12 5AB Royaume-Uni
(74) Agent	Mail recipient BRIDLE, ANDREW BARRY ET AL Bridle Intellectual Property Ltd 6F Thomas Way Lakeview International Business Park Canterbury Kent CT3 4JZ Royaume-Uni

(21) Request number	EP03787754.5
(22) Request date	08/08/2003

(11) Publication number	EP1529038
Publication date	07/10/2009

(54) Title of the invention	BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY
(51) International classification	C07D 277/68, C07D 417/12, A61K 31/428, A61P 29/00
International classification (before reform)	None

Claimed priority	(31) Number: 0218629 (32) Date: 09/08/2002 (33) Country: GB (31) Number: 0220955 (32) Date: 10/09/2002 (33) Country: GB
Initial application	None
Divisional application	None

Expected annuity	Annuity: 8 - Amount: 105 € - Due date 31/08/2010 Surtax: 8 - Amount: 21 € - Due date 01/03/2011
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2009/4, of 31/12/2009
History	Publication de la délivrance du brevet européen - Legal date 07/10/2009 Déchéance du brevet d'invention après période de grâce - Legal date 31/08/2011 Entrée en période de grâce du brevet d'invention - Legal date 31/08/2010